Fibrin-based drug delivery systems. II. The preparation and characterization of microbeads

Hsio O. Ho, Chih Chuan Hsiao, Chau Yang Chen, Theodore D. Sokoloski, Ming Thau Sheu

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

An emulsion method was employed to prepare fibrin beads having different sizes in this study. The oil phase of emulsion system was consisted of mineral oil with various amount of oleic acid as surfactant. Fibrin was converted from fibrinogen with thrombin in Tris buffer solution, then the mixture was emulsified into the oil phase forming droplets. After curing for one hour, 400 ul of glutaraldehyde solution (0.5% v/v) was added to minimize coagulation. The recovery of fibrin beads was simply done by decanting the oil phase and washing the residual with diethyl ether once and then with a mixture of isopropanol and n-hexane (1:3) containing 0.2% w/v Tween 80 twice. As expected, increasing the amount of oleic acid in the oil phase decreased the size of fibrin beads. It is due to the decrease of interfacial tension with increasing oleic acid amount. The presence of macromolecules showed no interference on the formation of fibrin beads except lysozyme. The diffusion characteristics of fibrin beads was evaluated using macromolecules of different molecular weight as model. The size of fibrin beads affected the penetration rate, whereas the effect of molecular weight of macromolecules was inconclusive. An exponential equation was able to approximate the penetration of macromolecules into fibrin beads during the late-time period. The possibility of using fibrin beads as the carrier to deliver protein drugs was appreciated.

Original languageEnglish
Pages (from-to)535-546
Number of pages12
JournalDrug Development and Industrial Pharmacy
Volume20
Issue number4
DOIs
Publication statusPublished - 1994

Fingerprint

Drug Delivery Systems
Fibrin
Microspheres
Macromolecules
Oils
Oleic Acid
Emulsions
Molecular Weight
Molecular weight
Mineral Oil
Tromethamine
Surface Tension
2-Propanol
Polysorbates
Glutaral
Muramidase
Coagulation
Washing
Surface-Active Agents
Thrombin

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Organic Chemistry
  • Molecular Medicine

Cite this

Fibrin-based drug delivery systems. II. The preparation and characterization of microbeads. / Ho, Hsio O.; Hsiao, Chih Chuan; Chen, Chau Yang; Sokoloski, Theodore D.; Sheu, Ming Thau.

In: Drug Development and Industrial Pharmacy, Vol. 20, No. 4, 1994, p. 535-546.

Research output: Contribution to journalArticle

Ho, Hsio O. ; Hsiao, Chih Chuan ; Chen, Chau Yang ; Sokoloski, Theodore D. ; Sheu, Ming Thau. / Fibrin-based drug delivery systems. II. The preparation and characterization of microbeads. In: Drug Development and Industrial Pharmacy. 1994 ; Vol. 20, No. 4. pp. 535-546.
@article{c1a5a1c5651b4a4085862e4e8be9677d,
title = "Fibrin-based drug delivery systems. II. The preparation and characterization of microbeads",
abstract = "An emulsion method was employed to prepare fibrin beads having different sizes in this study. The oil phase of emulsion system was consisted of mineral oil with various amount of oleic acid as surfactant. Fibrin was converted from fibrinogen with thrombin in Tris buffer solution, then the mixture was emulsified into the oil phase forming droplets. After curing for one hour, 400 ul of glutaraldehyde solution (0.5{\%} v/v) was added to minimize coagulation. The recovery of fibrin beads was simply done by decanting the oil phase and washing the residual with diethyl ether once and then with a mixture of isopropanol and n-hexane (1:3) containing 0.2{\%} w/v Tween 80 twice. As expected, increasing the amount of oleic acid in the oil phase decreased the size of fibrin beads. It is due to the decrease of interfacial tension with increasing oleic acid amount. The presence of macromolecules showed no interference on the formation of fibrin beads except lysozyme. The diffusion characteristics of fibrin beads was evaluated using macromolecules of different molecular weight as model. The size of fibrin beads affected the penetration rate, whereas the effect of molecular weight of macromolecules was inconclusive. An exponential equation was able to approximate the penetration of macromolecules into fibrin beads during the late-time period. The possibility of using fibrin beads as the carrier to deliver protein drugs was appreciated.",
author = "Ho, {Hsio O.} and Hsiao, {Chih Chuan} and Chen, {Chau Yang} and Sokoloski, {Theodore D.} and Sheu, {Ming Thau}",
year = "1994",
doi = "10.3109/03639049409038316",
language = "English",
volume = "20",
pages = "535--546",
journal = "Drug Development and Industrial Pharmacy",
issn = "0363-9045",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Fibrin-based drug delivery systems. II. The preparation and characterization of microbeads

AU - Ho, Hsio O.

AU - Hsiao, Chih Chuan

AU - Chen, Chau Yang

AU - Sokoloski, Theodore D.

AU - Sheu, Ming Thau

PY - 1994

Y1 - 1994

N2 - An emulsion method was employed to prepare fibrin beads having different sizes in this study. The oil phase of emulsion system was consisted of mineral oil with various amount of oleic acid as surfactant. Fibrin was converted from fibrinogen with thrombin in Tris buffer solution, then the mixture was emulsified into the oil phase forming droplets. After curing for one hour, 400 ul of glutaraldehyde solution (0.5% v/v) was added to minimize coagulation. The recovery of fibrin beads was simply done by decanting the oil phase and washing the residual with diethyl ether once and then with a mixture of isopropanol and n-hexane (1:3) containing 0.2% w/v Tween 80 twice. As expected, increasing the amount of oleic acid in the oil phase decreased the size of fibrin beads. It is due to the decrease of interfacial tension with increasing oleic acid amount. The presence of macromolecules showed no interference on the formation of fibrin beads except lysozyme. The diffusion characteristics of fibrin beads was evaluated using macromolecules of different molecular weight as model. The size of fibrin beads affected the penetration rate, whereas the effect of molecular weight of macromolecules was inconclusive. An exponential equation was able to approximate the penetration of macromolecules into fibrin beads during the late-time period. The possibility of using fibrin beads as the carrier to deliver protein drugs was appreciated.

AB - An emulsion method was employed to prepare fibrin beads having different sizes in this study. The oil phase of emulsion system was consisted of mineral oil with various amount of oleic acid as surfactant. Fibrin was converted from fibrinogen with thrombin in Tris buffer solution, then the mixture was emulsified into the oil phase forming droplets. After curing for one hour, 400 ul of glutaraldehyde solution (0.5% v/v) was added to minimize coagulation. The recovery of fibrin beads was simply done by decanting the oil phase and washing the residual with diethyl ether once and then with a mixture of isopropanol and n-hexane (1:3) containing 0.2% w/v Tween 80 twice. As expected, increasing the amount of oleic acid in the oil phase decreased the size of fibrin beads. It is due to the decrease of interfacial tension with increasing oleic acid amount. The presence of macromolecules showed no interference on the formation of fibrin beads except lysozyme. The diffusion characteristics of fibrin beads was evaluated using macromolecules of different molecular weight as model. The size of fibrin beads affected the penetration rate, whereas the effect of molecular weight of macromolecules was inconclusive. An exponential equation was able to approximate the penetration of macromolecules into fibrin beads during the late-time period. The possibility of using fibrin beads as the carrier to deliver protein drugs was appreciated.

UR - http://www.scopus.com/inward/record.url?scp=0028268379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028268379&partnerID=8YFLogxK

U2 - 10.3109/03639049409038316

DO - 10.3109/03639049409038316

M3 - Article

AN - SCOPUS:0028268379

VL - 20

SP - 535

EP - 546

JO - Drug Development and Industrial Pharmacy

JF - Drug Development and Industrial Pharmacy

SN - 0363-9045

IS - 4

ER -